SCHEMBL7797578

SCHEMBL7797578

CCOC(=O)C(CC(=O)c1ccc(C(F)(F)F)cc1)(NC(C)=O)C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
RECQL P46063 1/20 0.50
PKM P14618 2/20 0.49
KDM4E B2RXH2 1/20 0.49
THRB P10828 1/20 0.48
HTT P42858 2/20 0.47
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
POLB P06746 1/20 0.46
ATM Q13315 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PTPN1 P18031 2/20 0.43
GSK3B P49841 1/20 0.43
MMP1 P03956 1/20 0.42
EPHX2 P34913 1/20 0.41
PPARG P37231 1/20 0.41
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791489 0.85 ALDH1A1 (0.49) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL12912525 0.84 ALDH1A1 (0.52) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL5036126 0.84 ALDH1A1 (0.66) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL7797497 0.84 ALDH1A1 (0.45) ALDH1A1PKMMAPTNPSR1POLB
SCHEMBL7800751 0.83 ALDH1A1 (0.60) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL5402060 0.82 ALDH1A1 (0.60) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL10077498 0.82 ALDH1A1 (0.71) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL2463688 0.80 ALDH1A1 (0.44) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL16143340 0.80 ALDH1A1 (0.57) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL1925422 0.80 NPSR1 (0.55) ALDH1A1MAPTNPSR1POLBPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed
EP-0662948-B1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN SPA (IT) 1998-10-07 EP disclosed
EP-0662948-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1995-07-19 EP disclosed
WO-1995003271-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA S.P.A. (IT) 1995-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT ALDH1A1 615/4885RECQL 4560/4885PKM 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.